FDA Committee Urges New Warning On Antidepressants for Pregnancy
Jim Rosack in the Psychiatric News reports:
An FDA advisory committee says that despite a lack of conclusive data about potential harm, antidepressant labels should warn pregnant women that use of the medication could cause their newborn to suffer through withdrawal.
Leave a Reply